Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Clinical Trials Arena
Mon, 06/3/24 - 10:31 pm
Tags:
Takeda, Pfizer, Adcetris, clinical trials, Hodgkin's lymphoma
After two Big Pharma deals, Nimbus looks to keep the hits coming
Pharma Voice
Mon, 06/3/24 - 12:01 pm
Tags:
Nimbus Therapeutics, Gilead Sciences, MASH, Takeda
ASCO: GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive
Sun, 06/2/24 - 02:45 pm
Tags:
ASCO 2024, GSK, Blenrep, mutliple myeloma, Takeda, Velcade
Takeda, amid restructuring campaign, plots 641 layoffs at two Massachusetts sites
Fierce Pharma
Tue, 05/28/24 - 10:28 pm
Tags:
Takeda, layoffs, restructuring, Massachusetts
Takeda joins hot molecular glue market with $1.2B deal
BioSpace
Thu, 05/23/24 - 11:59 am
Tags:
Takeda, China, Degron Therapeutics, molecular glue
Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot
Pharmaphorum
Mon, 05/13/24 - 11:13 am
Tags:
Takeda, AC Immune, Alzheimer's disease, ACI-24.060
Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024
BioSpace
Thu, 05/9/24 - 11:38 am
Tags:
Takeda, Vyvanse, exclusivity
Takeda Pharma to restructure after annual profit slump
Reuters
Thu, 05/9/24 - 11:14 am
Tags:
Takeda, earnings, restructuring
A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach
BioSpace
Tue, 04/30/24 - 09:10 am
Tags:
Takeda, oncology, colorectal cancer, Fruzaqla, Annette Montandon
Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB
Fierce Pharma
Fri, 04/26/24 - 11:44 am
Tags:
Pfizer, UCB Pharma, WuXi AppTec, Takeda, BIO
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail
Fierce Biotech
Tue, 04/23/24 - 09:42 pm
Tags:
Neurocrine Biosciences, clinical trials, Takeda, major depressive disorder, Savitri
Pharmas form joint venture to jumpstart Japanese drug research
BioPharma Dive
Mon, 04/22/24 - 11:29 am
Tags:
Japan, R&D, Takeda, Astellas, Sumitomo Mitsui Banking
Takeda inks sweet $1.2B+ deal with Kumquat for immuno-oncology program
Fierce Biotech
Tue, 04/16/24 - 10:10 pm
Tags:
Takeda, Kumquat Biosciences, biobucks, immuno-oncology
Top five biopharma companies hiring in San Diego
BioSpace
Thu, 04/11/24 - 10:55 am
Tags:
San Diego, biotech, hirings, Avidity Biosciences, Element Biosciences, AnaptysBio, Fate Therapeutics, Takeda
Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS
Pharma Voice
Wed, 03/27/24 - 10:56 am
Tags:
Takeda, cliincal trials, TAK-279, Bristol Myers Squibb, clinical trial diversity, psoriasis
Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice
Fierce Pharma
Tue, 03/26/24 - 04:26 pm
Tags:
China, Pharma CEOs, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Novartis, Pfizer, Takeda
FDA Approves Iclusig for New Patients with Aggressive Leukemia
Managed Healthcare Executive
Tue, 03/19/24 - 09:20 pm
Tags:
Takeda, Iclusig, FDA, acute lymphoblastic leukemia
Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment
Clinical Trials Arena
Thu, 02/29/24 - 11:11 am
Tags:
Takeda, Eohilia, Sanofi, Dupixent, EoE, eosinophilic esophagitis
FDA approves Takeda's therapy for allergic inflammation in esophagus
Reuters
Mon, 02/12/24 - 10:21 am
Tags:
Takeda, FDA, Eohilia, eosinophilic esophagitis
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another
BioSpace
Fri, 02/9/24 - 11:18 am
Tags:
Takeda, clinical trials, TAK-861, narcolepsy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.